间充质干细胞对小鼠前列腺癌生长和血管生成促进作用的研究

唐礼功, 谢森, 潘铁军, 等. 间充质干细胞对小鼠前列腺癌生长和血管生成促进作用的研究[J]. 临床泌尿外科杂志, 2012, 27(9): 703-706.
引用本文: 唐礼功, 谢森, 潘铁军, 等. 间充质干细胞对小鼠前列腺癌生长和血管生成促进作用的研究[J]. 临床泌尿外科杂志, 2012, 27(9): 703-706.
TANG Ligong, XIE Sen, PAN Tiejun, et al. The effect of mesenchymal stem cells on angiogenesis of prostate cancer cell line RM-1 in vivo[J]. J Clin Urol, 2012, 27(9): 703-706.
Citation: TANG Ligong, XIE Sen, PAN Tiejun, et al. The effect of mesenchymal stem cells on angiogenesis of prostate cancer cell line RM-1 in vivo[J]. J Clin Urol, 2012, 27(9): 703-706.

间充质干细胞对小鼠前列腺癌生长和血管生成促进作用的研究

详细信息
    通讯作者: 谢森,E-mail:dr.xiesen@medmail.com.cn
  • 中图分类号: R737.25

The effect of mesenchymal stem cells on angiogenesis of prostate cancer cell line RM-1 in vivo

More Information
  • 目的:探讨间充质干细胞(marrow mesenchymal stem cells,MSCs)对RM-1小鼠前列腺癌细胞生长的影响及其可能机制。方法:从小鼠骨髓中无菌分离培养扩增MSCs。将MSCs与RM-1细胞混合后接种于Balb/c小鼠皮下,观察肿瘤生长情况;采用免疫组化法检测肿瘤组织血管生成情况(CD34染色);采用Realtime PCR法和ELISA法检测MSCs促进血管生成相关分子的表达情况。结果:MSCs与RM-1小鼠前列腺癌细胞混合后接种于Balb/c小鼠皮下,与对照组相比,MSCs可明显促进肿瘤生长(P<0.05);前列腺癌组织中CD34免疫组化染色结果证实MSCs组较对照组微血管密度显著升高(P<0.05);Realtime PCR及ELISA结果显示MSCs条件培养上清中VEGF表达显著升高。结论:MSCs可能通过表达VEGF促进前列腺癌血管形成,从而达到促进肿瘤生长的目的。
  • 加载中
  • [1]

    GRANERO-MOLTO F, WEIS J A, LONGOBARDI L, et al. Role of mesenchymal stem cells in regenerative medicine:application to bone and cartilage repair[J]. Expert Opin Biol Ther, 2008, 8(3):255-268.

    [2]

    VASHI A V, KERAMIDARIS E, ABBERTON K M, et al. Adipose differentiation of bone marrow-derived mesenchymal stem cells using Pluronic F-127 hydrogel in vitro[J]. Biomaterials, 2008, 29(5):573-579.

    [3]

    PACARY E, TIXIER E, COULET F, et al. Crosstalk between HIF-1 and ROCK pathways in neuronal differentiation of mesenchymal stem cells, neurospheres and in PC12 neurite outgrowth[J]. Mol Cell Neurosci, 2007, 35(3):409-423.

    [4]

    PORADA C D, ZANJANI E D, ALMEIDA-PORAD G. Adult mesenchymal stem cells:a pluripotent population with multiple applications[J]. Curr Stem Cell Res Ther, 2006, 1(3):365-369.

    [5]

    BANAS A, TERATANI T, YAMAMOTO Y, et al. Adipose tissue-derived mesenchymal stem cells as a source of human hepatocytes[J]. Hepatology, 2007, 46(1):219-228.

    [6]

    HUNG S C, DENG W P, YANG W K, et al. Mesenchymal stem cell targeting of microscopic tumors and tumor stroma development monitored by noninvasive in vivo positron emission tomography imaging[J]. Clin Cancer Res, 2005, 11(21):7749-7756.

    [7]

    NAKAMIZO A, MARINI F, AMANO T, et al. Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas[J]. Cancer Res, 2005, 65(8):3307-3318.

    [8]

    STUDENY M, MARINI F C, DEMBINSKI J L, et al. Mesenchymal stem cells:potential precursors for tumor stroma and targeted-delivery vehicles for anticancer agents[J]. J Natl Cancer Inst, 2004, 96(21):1593-1603.

    [9]

    KHAKOO A Y, PATI S, ANDERSON S A, et al. Human mesenchymal stem cells exert potent antitumorigenic effects in a model of Kaposi's sarcoma[J]. J Exp Med, 2006, 203(5):1235-1247.

    [10]

    LE BLANC K, RASMUSSON I, SUNDBERG B, et al. Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells[J]. Lancet, 2004, 363(9419):1439-1441.

  • 加载中
计量
  • 文章访问数:  28
  • PDF下载数:  42
  • 施引文献:  0
出版历程
收稿日期:  2012-07-17

目录